Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-07-01 Noble James Director Grant or award · Option to purchase Ordinary Shares +710,711 710,711
2021-07-01 Noble James Director Grant or award · Option to purchase Ordinary Shares +379,788 379,788
2020-07-01 Noble James Director Grant or award · Option to purchase Ordinary Shares +179,785 179,785
2020-05-29 Noble James Director Sale −500,000 $9.33 $4.7M 0
2020-04-01 Noble James Director Grant or award · Option to purchase Ordinary Shares +31,000 31,000
2020-01-13 Noble James Director Sale −100,000 $4.00 $400K 0
2020-01-13 Noble James Director Sale −200,000 $5.00 $1.0M 0
2019-05-16 Noble James Chief Executive Officer Option exercise +1,773,100 $0.14 $254K 1,773,100
2019-01-04 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +2,515,536 2,515,536
2019-01-04 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +561,792 561,792
2018-01-12 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +1,719,936 1,719,936
2018-01-12 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +384,120 384,120
2017-01-13 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +2,072,976 2,072,976
2016-01-18 Noble James Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +1,968,016 1,968,016

Page 1 of 1 · 14 trades